Korelasi antara Diameter Limpa dengan Jumlah Trombosit pada Pasien Sirosis Hati
Abstract
Tujuan: Mengetahui korelasi antara diameter limpa dengan jumlah trombosit pada pasien sirosis hati; Metode: Penelitian ini merupakan penelitian analitik observasional dengan pendekatan cross sectional. Subjek penelitian berjumlah 96 pasien sirosis hati pada RSUP Dr. M. Djamil Padang tahun 2019–2021. Pengambilan sampel dilakukan dengan teknik simple random sampling. Data dikumpulkan dalam bentuk data sekunder yaitu data diameter limpa dan jumlah trombosit pasien yang diperoleh melalui rekam medis. Korelasi antara diameter limpa dengan jumlah trombosit pada pasien sirosis hati dianalisis dengan uji korelasi Pearson; Hasil: Terdapat sebanyak 85,4% pasien mengalami pembesaran limpa dengan nilai rerata diameter limpa 13,88 ± 2,24 cm dan sebanyak 64,2% mengalami trombositopenia dengan nilai rerata jumlah trombosit 132.365 ± 66.296/mm3. Pada hasil uji korelasi Pearson antara diameter limpa dengan jumlah trombosit pada pasien sirosis hati, didapatkan nilai koefisien korelasi (r) = -0,564 dengan signifikansi (p) = 0,001 (p < 0,05); Kesimpulan: Terdapat korelasi yang bermakna antara diameter limpa dengan jumlah trombosit pada pasien sirosis hati dengan arah korelasi negatif dan nilai koefisien korelasi yang kuat.
Full Text:
PDFReferences
Moustafa N, Abdul M. Liver cirrhosis: An overview. Merit Res J Med Med Sci. 2016;4(7):329–43.
Natarajan V, Harris EN, Kidambi S. SECs (sinusoidal endothelial cells), liver microenvironment, and fibrosis. Biomed Res Int. 2017;2017:1–9.
Nurdjanah S. Sirosis hati. In: Setiati S, Alwi I, Sudoyono AW, Marcellus S, Setyohadi B, Syam AF, editor. Buku ajar ilmu penyakit dalam. 6 ed. Interna Publishing; 2017. hal. 1980–5.
World Health Organization. Global health estimates: leading causes of death [Internet]. [dikutip 28 Februari 2022]. Tersedia pada: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650–66.
Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: A review of available epidemiological data. J Hepatol. 2013;58(3):593–608.
Nurdjanah S. Sirosis Hati. In: Sudoyono AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, editor. Buku ajar ilmu penyakit dalam. 4 ed. 2009. hal. 668–73.
Perhimpunan Peneliti Hati Indonesia - PPHI [Internet]. [dikutip 28 Februari 2022]. Tersedia pada: https://pphi-online.org/alpha/?p=570
Purba RW. Karakteristik penderita sirosis hati yang dirawat inap di Rumah Sakit Umum Pusat Haji Adam Malik Medan tahun 2017 (Skripsi). Medan: Universitas Sumatera Utara; 2018.
Maharani S, Efendi D, Tampubolon LA. Gambaran pemeriksaan fungsi hati pada pasien sirosis hepatis yang dirawat di Rumah Sakit Umum Daerah Arifin Achmad Provinsi Riau periode 2013 - 2015. J Med Sci. 2019;12(1):46–51.
World Health Organization. Liver cirrhosis (15+), age-standardized death rates - by country [Internet]. [dikutip 28 Februari 2022]. Tersedia pada: https://apps.who.int/gho/data/view.main.53420
Lovena A, Miro S, Efrida E. Karakteristik pasien sirosis hepatis di RSUP Dr. M. Djamil Padang. J Kesehat Andalas. 2017;6(1):5–12.
Putri TR. Gambaran penderita sirosis hepatis berdasarkan klasifikasi Child Turcotte Pugh dan penyebab kematian di RSUP DR. M. Djamil Padang (Skripsi). Padang: Universitas Andalas; 2018.
Al-Busafi SA, McNabb-Baltar J, Farag A, Hilzenrat N. Clinical manifestations of portal hypertension. Int J Hepatol. 2012;2012:1–10.
Albilllos A, Garcia-Tsao G. Classification of cirrhosis: The clinical use of HVPG measurements. Dis Markers. 2011;31(3):121–8.
Sharma M, Rameshbabu CS. Collateral pathways in portal hypertension. J Clin Exp Hepatol. 2012;2(4):338–52.
Bandali MF, Mirakhur A, Lee EW, Ferris MC, Sadler DJ, Gray RR, et al. Portal hypertension: Imaging of portosystemic collateral pathways and associated image-guided therapy. World J Gastroenterol. 2017;23(10):1735–46.
Vidyani A, Vianto D, Widodo B, Kholili U, Maimunah U, Sugihartono T. Faktor risiko terkait perdarahan varises esofagus berulang pada penderita sirosis hati. J Penyakit Dalam. 2011;12(3):169–74.
Li L, Duan M, Chen W, Jiang A, Li X, Yang J, et al. The spleen in liver cirrhosis: revisiting an old enemy with novel targets. J Transl Med. 2017;15(1):1–10.
Suttorp M, Classen CF. Splenomegaly in children and adolescents. Front Pediatr. 2021;9:693.
Tekle Y, Hiware S, Abreha M, Muche A, Ambaw M, Desita Z. Determination of normal dimension of the spleen by ultrasound and its correlation with age. 2019;7:AT08_AT11.
Indiran V, Vinod Singh N, Ramachandra Prasad T, Maduraimuthu P. Does coronal oblique length of spleen on CT reflect splenic index? Abdom Radiol. 2017;42(5):1444–8.
Berzigotti A, Zappoli P, Magalotti D, Tiani C, Rossi V, Zoli M. Spleen enlargement on follow-up evaluation: A noninvasive predictor of complications of portal hypertension in cirrhosis. Clin Gastroenterol Hepatol. 2008;6(10):1129–34.
Vancauwenberghe T, Snoeckx A, Vanbeckevoort D, Dymarkowski S, Vanhoenacker FM. Imaging of the spleen: What the clinician needs to know. Singapore Med J. 2015;56(3):133–44.
Tsuji H, Fujishima M. Hypersplenism in liver cirrhosis. Nihon Rinsho. Januari 1994;52(1):85–90.
Theodore E, Warkentin. Thrombocytopenia caused by platelet destruction, hypersplenism, or hemodilution. In: Hoffman R, J. Benz, Jr. E, Silberstein LE, Heslop HE, Weitz JI, Anastasi J, et al., editor. Hematology: Basic principles and practice. 7 ed. Elsevier; 2018. hal. 1955–72.
Lv Y, Lau WY, Li Y, Deng J, Han X, Gong X, et al. Hypersplenism: History and current status. Exp Ther Med. 2016;12(4):2377–82.
Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int. 2017;37(6):778–93.
Sigal SH, Sherman Z, Jesudian A. Clinical implications of thrombocytopenia for the cirrhotic patient. Hepat Med. 2020;12:49–60.
Nugraha G, Badrawi I. Hitung jumlah trombosit. In: Pedoman teknik pemeriksaan laboratorium klinik. Jakarta: Trans Info Media; 2018. hal. 32–7.
Saab S, Bernstein D, Hassanein T, Kugelmas M, Kwo P. Treatment options for thrombocytopenia in patients with chronic liver disease undergoing a scheduled procedure. J Clin Gastroenterol. 2020;54(6):503–11.
Moore AH. Thrombocytopenia in Cirrhosis: A review of pathophysiology and management options. Clin Liver Dis. 2019;14(5):183–6.
Taksande A, Saqqaf SA, Damke S, Meshram R. Diagnostic accuracy of different methods of palpation and percussion of spleen for detection of splenomegaly in children. Ann Med Health Sci Res. 2021;11:89–93.
Olson APJ, Trappey B, Wagner M, Newman M, Nixon LJ, Schnobrich D. Point-of-care ultrasonography improves the diagnosis of splenomegaly in hospitalized patients. Crit Ultrasound J. 2015;7(1):13.
Das S. Examinations on chronic abdominal conditions. In: A manual on clinical surgery. 13 ed. Kolkata: DAS publications; 2018. hal. 482–517.
Inayyatullah M, Nasir SA. Alimentary and genito-urinary system. In: Bedside techniques: Methods of clinical examination. 4 ed. Pakistan: Paramount Publishing Enterprise; 2013. hal. 107–34.
Moore KL, Dalley FA, Agur AMR. Clinical box: Spleen and pancreas. In: Clinically oriented anatomy. 8 ed. Philadelphia: Wolters Kluwer; 2018. hal. 1183–90.
